Infectious Disease Training in Clinical Investigation
Infectious Disease Training in Clinical Investigation
批准号:
6658845
负责人:
PHILLIP Keith PETERSON
金额:
$22.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-08-31
中文摘要
描述(由申请人提供):我们提出了一个医学微生物学奖学金计划,将提供适当的实验室诊断,控制和感染性疾病的治疗方法的培训。该计划的毕业生将有资格熟练地管理诊断微生物学实验室,与临床医生就医学微生物学测试的选择和解释进行咨询,建立和指导医疗机构的感染控制计划,并领导抗生素处方委员会,以优化抗菌药物的明智使用,并最大限度地减少对这些化合物的耐药性的出现。他们还将接受培训,以设计和开展研究项目,从而推动该领域的科学进步。在寻求资助这个奖学金的一个主要激励因素是认识到微生物实验室和临床医生之间的沟通是必要的,以正确选择和解释测试和结果,该计划将是独特的,其重点是临床医生和微生物学家之间的沟通技能的发展。它将由两个医学博士共同指导。和博士训练有素的微生物学家,这将加强培训计划,因为每个人都为传染病的诊断和研究带来了独特的视角和背景。沿着这些相同的概念,我们将提供一个位置,以医学博士。候选人和一个博士职位。候选人,每年总共有两名研究员,他们将在培训期间密切互动和合作。该计划将提供至少两年,但不超过三年的每一个受训者。从培训的第二年开始,至少有一年的时间专门用于临床微生物学主要研究项目的研究工作。培训将集中在埃文斯顿西北医疗保健(ENH),西北大学在埃文斯顿,伊利诺伊州,已连续七年被评为美国前15名教学医院之一的麦高医学中心的成员。我们的课程将符合美国病理学委员会(ABP)和美国微生物学学会研究生教育计划委员会(CPEP)的认证指南。完成该计划的研究员将有资格获得美国病理学委员会(ABP -适用于具有医学博士学位的人)的委员会认证。和/或美国医学微生物学委员会(ABMM -适用于具有M.D.或Ph.D.)。
参与教师:培训教师35人,其中教授16人,副教授4人,助理教授7人。 培训教员中有六名妇女。29名教师在明尼苏达大学,5名在明尼苏达州卫生部。 主要研究领域包括:病毒发病机制、艾滋病毒/艾滋病、侵入性细菌感染、抗生素耐药性、粘膜免疫、免疫功能低下的患者、国际和移民健康、生物恐怖主义和食源性感染。
英文摘要
DESCRIPTION (provided by applicant): We propose a Medical Microbiology fellowship program that will provide training in the appropriate laboratory diagnosis, control, and approach to the treatment of infectious diseases. Graduates of the program will be qualified to expertly manage the diagnostic microbiology laboratory, consult with clinicians on the selection and interpretation of medical microbiology tests, establish and direct the infection control program for a healthcare organization, and lead the antibiotic formulary committee so as to optimize the wise use of antimicrobial agents and minimize the emergence of resistance toward these compounds. They will also be trained to design and conduct research projects leading to scientific advancement in the field. A primary motivating factor in seeking funding for this fellowship is recognition that communication between the microbiology laboratory and the clinician is essential to proper selection and interpretation of tests and results, and this program will be unique in its focus on the development of communication skills between clinician and microbiologist. It will be co-directed by both a M.D. and a Ph.D. trained Microbiologist, which will enhance the training program, as each brings a distinct perspective and background to the diagnosis and research of infectious diseases. Along those same concepts, we will offer one position to a M.D. candidate and one position to a Ph.D. candidate, for a total of two fellows per year who will interact and collaborate closely during their training. This program will be offered for a minimum of two years but no more than three years for each trainee. A minimum of one year will be devoted solely to research efforts on a major research project in clinical microbiology, beginning in the second year of training. The training will be centered at Evanston Northwestern Healthcare (ENH), a member of the McGaw Medical Center of Northwestern University in Evanston, Illinois, which has been named one of America's top 15 teaching hospitals for seven consecutive years. Our program will comply with both American Board of Pathology (ABP) and American Academy of Microbiology Committee on Postgraduate Educational Programs (CPEP) guidelines for accreditation. Fellows completing this program would be eligible for board certification by either the American Board Pathology (ABP - available for those with a M.D.) and/or the American Board of Medical Microbiology (ABMM - available for those with a M.D. or Ph.D.).
PARTICIPATING FACULTY: The 35 training faculty include 16 professors, four associate professors, and seven assistant professors. Six of the training faculty are women. Twenty-nine of the faculty are at the University of Minnesota and five are with the Minnesota Department of Health. The primary areas of research include: viral pathogenesis, HIV/AIDS, invasive bacterial infections, antibiotic resistance, mucosal immunity, immunocompromised patients, international and immigrant health, bioterrorism and foodborne infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infectious Disease Training in Clinical Investigation
-
批准号:7116326
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2003
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:6940835
-
项目类别:
-
资助金额:$27.24万
-
财政年份:2003
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:6792180
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2003
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:6634221
-
项目类别:
-
资助金额:$26.59万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Dynorphin and Glial Cell Immunomodulation
-
批准号:6745343
-
项目类别:
-
资助金额:$30.17万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Dynorphin and Glial Cell Immunomodulation
-
批准号:7173133
-
项目类别:
-
资助金额:$18.48万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Dynorphin and Glial Cell Immunomodulation
-
批准号:7228546
-
项目类别:
-
资助金额:$31.89万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:2794136
-
项目类别:
-
资助金额:$24.61万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Dynorphin and Glial Cell Immunomodulation
-
批准号:6869501
-
项目类别:
-
资助金额:$11.76万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:2713127
-
项目类别:
-
资助金额:$24.53万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:6174831
-
项目类别:
-
资助金额:$24.33万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:6515553
-
项目类别:
-
资助金额:$25.82万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
DYNORPHIN AND GLIAL CELL IMMUNOMODULATION
-
批准号:6378629
-
项目类别:
-
资助金额:$25.06万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Dynorphin and Glial Cell Immunomodulation
-
批准号:7013632
-
项目类别:
-
资助金额:$32.85万
-
财政年份:1995
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
MECHANISMS OF IMMUNOLOGICALLY MEDIATED FATIGUE
-
批准号:2704867
-
项目类别:
-
资助金额:$17.49万
-
财政年份:1994
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES
-
批准号:2117164
-
项目类别:
-
资助金额:$36.4万
-
财政年份:1987
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES
-
批准号:2117165
-
项目类别:
-
资助金额:$33.49万
-
财政年份:1987
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
MODULATION OF CELL-MEDIATED IMMUNE FUNCTION BY OPIATES
-
批准号:6175228
-
项目类别:
-
资助金额:$34.73万
-
财政年份:1987
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Modulation of Cell-Mediated Immune Function by Opiates
-
批准号:6727618
-
项目类别:
-
资助金额:$43.38万
-
财政年份:1987
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
Modulation of Cell-Mediated Immune Function by Opiates
-
批准号:6844308
-
项目类别:
-
资助金额:$28.82万
-
财政年份:1987
-
负责人:PHILLIP Keith PETERSON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
骨髓基质干细胞移植对AD(Alzheimer disease)小鼠海马及额叶神经细胞死亡干预的实验研究
-
批准号:81301089
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:商敬伟
-
依托单位:
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
Batten Disease (BD)神经元退化病理机制的研究
-
批准号:30900802
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:吴丹
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: